ScoreWhy is Prime Medicine, Inc. ?
1
Positive results in Jun 25
- NET SALES(HY) At USD 2.57 MM has Grown at 334.69%
- OPERATING CASH FLOW(Y) Highest at USD -99.94 MM
- NET PROFIT(HY) Higher at USD -102.92 MM
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 31.32%, its profits have fallen by -4.1%
3
Market Beating Performance
- The stock has generated a return of 31.32% in the last 1 year, much higher than market (S&P 500) returns of 15.98%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Prime Medicine, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Prime Medicine, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Prime Medicine, Inc.
35.89%
-0.46
112.89%
S&P 500
13.02%
0.81
19.85%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
81.31%
EBIT Growth (5y)
-36.99%
EBIT to Interest (avg)
-162.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.29
Sales to Capital Employed (avg)
0.02
Tax Ratio
0.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
43.46%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.08
EV to EBIT
-0.41
EV to EBITDA
-0.42
EV to Capital Employed
-2.77
EV to Sales
21.97
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-186.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
NET SALES(HY)
At USD 2.57 MM has Grown at 334.69%
OPERATING CASH FLOW(Y)
Highest at USD -99.94 MM
NET PROFIT(HY)
Higher at USD -102.92 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 82.68 times
-4What is not working for the Company
ROCE(HY)
Lowest at -154.81%
RAW MATERIAL COST(Y)
Grown by 6,717% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 29.55 %
Here's what is working for Prime Medicine, Inc.
Net Sales
At USD 2.57 MM has Grown at 334.69%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -102.92 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -99.94 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Highest at 82.68 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at USD 1.86 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Prime Medicine, Inc.
Debt-Equity Ratio
Highest at 29.55 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 6,717% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
